![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![Short-term use of ibuprofen may increase chance of chronic pain, study suggests | Health | The Guardian Short-term use of ibuprofen may increase chance of chronic pain, study suggests | Health | The Guardian](https://i.guim.co.uk/img/media/da1d764409f6da4655e83993cc0a3a66dc31f5bb/0_549_8192_4915/master/8192.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=a909d32e43e8fdadb7551034347a308e)
Short-term use of ibuprofen may increase chance of chronic pain, study suggests | Health | The Guardian
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png?1662701546)